glp-1 weight loss comparison GLP-1R Agonists for Comparison of approved GLP-1 RAs

After a series of negotiations, the administration announced agreements with the two firms

GLP-1 receptor agonists mimic natural GLP-1

These positive comments generated notable positive sentiment toward Novo Nordisks developments in addiction therapies (23.1k X views)

On April 21, 2026, the day after the application deadline for Medicare Part D plan sponsors to participate in the BALANCE Model, CMS announced that it would not be moving forward with implementation of the BALANCE Model in Medicare in 2027 and instead would be extending the Medicare GLP-1 Bridge to run through the end of 2027

Reference lists of included articles were also screened to identify further relevant studies